Back to News
Market Impact: 0.2
Ping An Biomedical Announces 1-for-40 Reverse Stock Split
Source: globenewswire.com
Company FundamentalsManagement & Governance
Ping An Biomedical's board approved a 1-for-40 reverse stock split of its Class A and Class B ordinary shares. The announcement provides no additional details on timing or rationale.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
-0.05
More News
- The U.S. market has never been more focused on one single bet—but AI’s payoff will likely take decades
- Meta put out an ambitious roadmap to Muse monetization after strong quarter and guide
- CoreWeave’s market confidence erodes as bond yields spike and stock sinks
- Why is Tesla stock falling after-hours today?
- Meta ordered to pay $25 billion in case related to Cambridge Analytica scandal
- Zuckerberg told Meta directors he might leave California, where he could lose billions to a wealth tax. Meta answered with a new class of stock
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- How to Search Earnings Call Transcripts With AI
- What a Concept From Nature Tells Us About How C-Suite Executives Actually Think About AI